Corneal cross-linking (CXL), also known as collagen cross-linking, is an outpatient treatment to strengthen the corneal stroma. This is achieved by means of creating new chemical bonds between the stroma fibres.
CXL is to date the only procedure known to be successful when treating advanced stages of keratoconus and related ectatic diseases such as pellucid marginal degeneration and iatrogenic corneal ectasia.
Since its introduction in 2006, several tens of thousands of patients have been successfully treated.
In order to protect the limbal stem cells and to place the beam exactly on the cornea, CCL-Vario’s beam diameter is 7-11 mm.
CCL-Vario can be mounted using a table fixture and transported in a stable case.